Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Lask

2 clinical trials in Lask, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Lask at a glance
2
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Lask

Open in trial search

Cardiovascular disorder

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Cardiac failure

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 238 cities in Poland

Clinical research in Lask

What the registry says about research in the country

01 Lask
Cardiovascular Diseases
Clinical trial activity in Lask includes research in cardiovascular diseases, with a focus on improving outcomes for people at risk of serious heart and blood vessel complications. The studies are designed to assess whether new treatment approaches can better protect patients alongside standard care. Cardiovascular disease Heart failure with mildly reduced or preserved ejection fraction Reducing the risk of cardiovascular death and heart failure events Evaluating a new therapy against placebo in patients with inflammation-related heart failure These trials reflect a strong interest in better treatment options for complex heart conditions, especially where inflammation may play a role.
Nutritional and Metabolic Diseases
Another area of research in this city is nutritional and metabolic diseases, with clinical studies exploring whether novel therapies can help lower the chance of major cardiovascular events. The aim is to support prevention strategies for people living with heart and metabolic risk. Prevention of major adverse cardiovascular events Testing a new treatment approach for long-term heart risk reduction Comparing active therapy with placebo to confirm treatment benefit Research focused on patients with ongoing cardiovascular vulnerability The work in Poland brings together heart and metabolic research to evaluate whether emerging therapies can improve everyday clinical outcomes.
Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.